Quick Answer
Inogen Inc reported Research And Development Expense of $19.40 million for the year ending 2025.
- Inogen Inc showed a decrease of -10.2% in Research And Development Expense from 2024 to 2025.
- This data is from Inogen Inc's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Inogen Inc's Research And Development Expense has grown by 757.6%.
- Historical annual values: Fiscal year 2025: $19.40 million | Fiscal year 2024: $21.61 million | Fiscal year 2023: $20.84 million | Fiscal year 2022: $21.94 million | Fiscal year 2021: $16.58 million | Fiscal year 2020: $14.08 million | Fiscal year 2019: $9.40 million | Fiscal year 2018: $7.03 million | Fiscal year 2017: $5.31 million | Fiscal year 2016: $5.11 million | Fiscal year 2015: $4.18 million | Fiscal year 2014: $2.98 million | Fiscal year 2013: $2.40 million | Fiscal year 2012: $2.26 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: